Waverley Pharma Inc (WAVE) — Cash Flow-to-Debt Ratio
Waverley Pharma Inc (WAVE) has a Cash Flow-to-Debt Ratio of -0.04x as of September 2025, meaning its operating cash flow of CA$-138.86K could theoretically repay 0% of its total liabilities (CA$3.64 Million) in one year. Check Waverley Pharma Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Waverley Pharma Inc Cash Flow-to-Debt Ratio (2015–2024)
Historical debt coverage capacity for Waverley Pharma Inc across 10 annual periods. Also explore WAVE total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Waverley Pharma Inc (2015–2024)
Year-by-year debt coverage analysis for Waverley Pharma Inc. For market capitalisation and broader financial context, see market value of Waverley Pharma Inc.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.10x | CA$-410.19K | CA$4.08 Million | ▲ +79.4% |
| 2023 | -0.49x | CA$-1.02 Million | CA$2.09 Million | ▼ -229.1% |
| 2022 | -0.15x | CA$-237.06K | CA$1.60 Million | ▲ +64.8% |
| 2021 | -0.42x | CA$-798.78K | CA$1.89 Million | ▼ -68.9% |
| 2020 | -0.25x | CA$-361.70K | CA$1.45 Million | ▲ +72.6% |
| 2019 | -0.91x | CA$-1.41 Million | CA$1.55 Million | ▲ +20.6% |
| 2018 | -1.15x | CA$-1.45 Million | CA$1.26 Million | ▼ -1592.1% |
| 2017 | -0.07x | CA$-108.69K | CA$1.60 Million | ▲ +99.3% |
| 2016 | -9.27x | CA$-108.69K | CA$11.72K | ▲ +9.2% |
| 2015 | -10.21x | CA$-108.69K | CA$10.65K | — |